Contribution: Industrial Research Assistance Program – Contributions to Firms
Nanil Therapeutics Inc
$75,000.00
POC of AI-Nano-antibody design and Validation for AD
EF 2025-26 · 2025-09-01
Résumé
Nanil Therapeutics is validating its proprietary BioDesign-AI platform through experimental assessment of AI-generated nanobody sequences targeting tau, a key protein in Alzheimer’s disease.
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Calgary|Calgary, Alberta, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
720648021
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Tel que publié
Agreement End Date
2026-01-02
Agreement Number
1034082
Agreement Start Date
2025-09-01
Agreement Title
POC of AI-Nano-antibody design and Validation for AD
Agreement Title (French)
Conception et validation de nanocorps IA pour la maladie d’Alzheimer (PdC)
Agreement Type
Contribution
Agreement Value
$75,000.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Nanil Therapeutics is validating its proprietary BioDesign-AI platform through experimental assessment of AI-generated nanobody sequences targeting tau, a key protein in Alzheimer’s disease.
Description (French)
Nanil Therapeutics valide sa plateforme exclusive BioDesign-AI par l’évaluation expérimentale de séquences de nanocorps générées par l’IA ciblant la protéine tau, une protéine clé de la maladie d’Alzheimer.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Calgary Confederation
Federal Riding (French)
Calgary Confederation
Federal Riding Number
48005
NAICS Code
3254
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
720648021
Recipient City
Calgary|Calgary
Recipient Country
CA
Recipient Legal Name
Nanil Therapeutics Inc
Recipient Operating Name
Nanil Therapeutics Inc.
Recipient Postal Code
T2L 1Y8
Recipient Province or Territory
AB
Recipient Type
F
Reference Number
172-2025-2026-Q2-1034082
